Recent technological advances have increased drastically the number of experiments or assays one can performwith asmall team of researchersa nd am anageable seto fi nstruments.T he resulting reduction in time and cost makes it feasible to performl arge-scale studies. While researchersc an produce enormous amountso fd ata over as hortp eriod of time with fundingf roma na verage research grant, extracting useful information from thed ata is ac hallenge,t he difficulty of which most large-scale studies underestimate.U sually understaffed, and with an inadequate budget, the analysist eams often lack the proper analytical tools, yeth avet he unenviable task of drawing conclusionsf romd ata without af ull understandingofthe conditionsunder which the data were obtained or the tools used today. Unless we paym ore attention to data analysis, we will soon drowni nasea of conflicting data and miss the biological patterna nd information hiddenw ithin them.
controls must be taken into account, or spurious associations will result or true associations mayb em issed.
In proteomics, advances in protein separation and mass spectrometrym akei tp ossible to obtain protein profiles of biological materials in terms of both the specific proteins present and their relative abundance.E venw ith ag ood catalogue of proteinsf ound in as pecimen, however, the fact that most tissue specimens consist of amixture of different types of cells, and that they are obtained under slightly different physiological conditions, creates ag reatd eal of additional noise in the system. It is no surprise,therefore, that proteomic data can only be analysed in aq ualitativea nd superficial way.
In gene expression profiling, probably them ost mature formo fl arge-scale studies in the genomics field, intriguing patterns of expressions are seen when one compares different tissues. Once again,h eterogeneity in the tissuess tudied and differences in the conditionsu nder which the samples are obtained affect the gene expression patterns in significant ways. Even so,ins ome cases, one can predict the prognosis of ap atientb yl ooking at the expression patterno fc ancerous tissue.T here is, however, still great uncertainty in the predictivev alue of gene expression profiling as ad iagnostic tool. Much liket he case of proteomics,t hese patterns will not lead to ad eeperu nderstanding of the biological pathwaysi nvolved in ad isease without careful cell biology studies.
Given these difficulties, howdoes one takeadvantage of the amazingt echnologies available in the fieldso fg enomics and proteomics? Ib elievet hat the field must restrain from generating data for its ownsake. Instead, one must face the problem head on and taket he following actions.
First, one must define the specimens under study witha great deal more detail, so that one is comparing different specimens that area ppropriately grouped. Fore xample, instead of labellingDNA samples simply as being from patients having ac ertain disease or from ag roup of 'normalc ontrols', one should define thes pecimens further witha sm uch phenotypic and demographic information as possible,i ncluding, at very least, carefully defined clinical diagnoses, keyl aboratoryfi ndings, major clinicalf eatures, agea td isease onset, sex and ethnico rigins of the four grandparents (including their places of birth and self-described ancestry). Instead of labelling tissue samples for RNA or protein studies simply as 'tumour', 'tissue with actived isease' or 'normal tissue', one should include not only the phenotypic and demographic information needed for DNA samples, but also information on the conditionsu nder which the tissue waso btained. In some cases, it is important to note whether as pecimen is obtained under fasting conditions or shortly after am eal, in the morningo ri nt he evening, while the person has been at rest or after ap eriod of activity.A so ne carefully controls for the 'background' of the DNA or tissues pecimens, noise is greatly reduced and the resultant signals are more easily identified.
Secondly,t he accuracy of the data must be determined by periodicv alidation of the molecular methods and by inclusion of proper controls in the study.W hether one is performing DNA sequencing, genotyping of genetic markers, determining the global gene expression patterns of at issue or profiling the protein contento facell type,q uality control must be done consistently throughout the course of as tudy.K nowing the degree of uncertainty in the data, and takingt his into account during data analysis, enhancest he powero ft he analysis and strengthens the conclusions derived from the results. Te sting duplicate samples at various time pointsd uring the study, repeating as ubset of experiments using ad ifferent platform and looking for consistency of thed ata based on family or other sample relationships ares ome of the ways one can determine the quality of the data.
Thirdly,i ti se ssential to develop analyticalt ools that are appropriate for the data, so that they can be applied properly. In many cases, standard statisticalm ethods cannot be used for genomic,g ene expression or proteomic data obtained from a heterogeneous group of individuals. Because biological data are so complex, and one cannot control with greatp recision the conditionsu nder which the samples are obtained, the assumptions of standard statistical tools regarding the data properties cannot be met. Without proper understanding of the conditions required for astatistical method to be valid, one can apply the wrong test for ad ataset and obtain erroneous results. Biostatisticians are becoming more familiarw ith the explosiono fg enomic,g ene expression and proteomic data being produced and, in due time,a na ppropriate set of analyticalm ethods will be available for all to use.
Until these practices arestandard in thefield, one has to take the results and conclusionsoflarge-scale studies with ahealthy dose of scepticism. Journal reviewersmust insist that those who want to publish the results of genomic,geneexpression or proteomic studies address the questions of phenotypic,population and specimen heterogeneity,data quality and the rationale for their choice of analytical method for their data. When these issues are properly addressed, the quality of publications in our field will drastically improve, the number of studies showing conflicting results will decrease and the daywhen we will decipher the mysteries of the biological patterns contained in our genome and proteome will arrive much sooner.
